Main > MEDICINE > Medical Diagnostics > Nucleic Acid > DNA > Mass Spectrometry. > MALDITOF Mass Spectrometry

Product USA. S

PATENT NUMBER This data is not available for free
PATENT GRANT DATE 31.12.02
PATENT TITLE DNA diagnostics based on mass spectrometry

PATENT ABSTRACT Fast and highly accurate mass spectrometry-based processes for detecting particular nucleic acid molecules and sequences in the molecules are provided. Depending upon the sequence to be detected, the processes, for example, can be used to diagnose a genetic disease or a chromosomal abnormality, a predisposition to a disease or condition, or infection by a pathogen, or for determining identity or heredity
PATENT INVENTORS This data is not available for free
PATENT ASSIGNEE This data is not available for free
PATENT FILE DATE February 28, 2001
PATENT REFERENCES CITED Adler et al. "Cell Membrane Coating with Glutaraldehyde: Application to a versatile Solid-Phase Assay for Thyroid Membrane Proteins and Molecules Interacting with Thyroid Membranes," Analytical Chemistry 148:320-327 (1985).
Andersen, et al., Electrospray ionization and matrix assisted laser desorption/ionization mass spectrometry: Powerful analytical tools in recombinant protein chemistry, Nature Biotech. 14: 449-457 (1996).
Ardrey, Bob, Electrospray mass spectrometry, Spectroscopy Europe 4: 10-20 (1992).
Arlinghaus et al., "Applications of resonance ionization spectroscopy for semiconductor, environmental and biomedical analysis, and for DNA sequencing," SPIE, vol. 1435, Opt. Methods Ultrasensitive Detect. Anal. Tech. Appl. pp. 26-35 (1991).
Barany F., Genetic disease detection and DNA amplification using cloned thermostable ligase, Proc. Natl. Acad. Sci. 88: 189-193 (1991).
Barrell, DNA Sequencing: Present Limitations and Prospects for the Future, FASEB Journal 5: 40-45 (1991).
Beck et al., Applications of dioxetane chemiluminescent probes to molecular biology, Anal. Chem. 62: 2258-2270 (1990).
Beck et al., Chemiluminescent detection of DNA: application for DNA sequencing and hybridization, Nucl Acids Res 17: 5115-5123 (1989).
Berkenkamp et al., Infrared MALDI mass spectrometry of large nucleic acids, Science 281: 260-262 (1998).
Braun et al., Improved Analysis of Microsatellites Using Mass Spectrometry, Genomics 46: 18-23 (1997).
Braun et al., Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry, Clinical Chemistry 43: 1151-1158 (1997).
Broude et al., Enhanced DNA sequencing by hybridization, Proc. Natl. Acad. Sci. USA 91: 3072-3076 (1994).
Caldwell et al., Mid-infrared matrix assisted laser desorption ionization with a water/glycerol matrix, Applied Surface Science 127-129: 242-247 (1998).
Chakrabarti et al., Sequence of simian immunodeficiency virus from macaque and its relationship to other human simian retroviruses, Nature 328: 543-547 (1987).
Chee, Enzymatic multiples DNA sequencing, Nucleic Acids Res. 19(12): 3301-3305 (1991).
Chen et al., "Laser mass spectrometry for DNA fingerprinting for forensic applications", Annual Meeting of the Society of Photo Optical Instrumentation Engineers, Jul. 24-29, 1994.
Chrisey et al., Fabrication of patterned DNA surfaces, Nucl. Acids. Res. 24: 3040-3047 (1996).
Chrisey et al., Covalent attachment of synthetic DNA to self-assembled monolayer films, Nucl. Acids Res. 24: 3031-3039 (1996).
Connolly, Oligonucleotides Containing Modified Bases, Oligonucleotides and Analogues, A Practical Approach, Edited by F. Eckstein, Oxford University Press Ch. 7, pp. 155-183 (1991).
Covey, et al., The determination of protein, oligonucleotide and peptide molecular weights by ion-spray mass spectrometry, Rapid Comm. Mass Spectrom. 2: 249-256 (1988).
Crain, Mass spectrometric techniques in nucleic acid research, Mass Spectrom. Rev. 9: 505-554 (1990).
Database WPI, WPI Acc. No. 96140362/199615, citing German Patent No. DE4431174 published Mar. 7, 1996 [see item DV].
Database WPI, WPI Acc. No. 96222896/199623, citing German Patent No. DE4438630 published May 2, 1996 [see item DW].
Derwent #010108710 WPI Acc. No. 95-009963/199502 (citing, Japanese Patent Application No. JP 6294796, published Oct. 21, 1994) [see item DX].
Derwent #01022178 WPI Acc. No. 95-123433/199516 (citing International PCT application No. WO 9507361, published Mar. 16, 1995) [see item EQ].
Derwent #007515331 WPI Acc. No. 88-149264/198822 (citing, European Patent Application No. EP 269520, published Jun. 1, 1988) [see item DO].
Derwent #008221916 WPI Acc. No. 90-108917/199015 (citing, European Patent Application No. EP 360677, published Mar. 28, 1990) [see item DP].
Derwent #008541935 WPI Acc. No. 91-045998/199107 (citing, European Patent Application No. EP 412883, published Feb. 13, 1991) [see item DO].
Derwent #001797565 WPI Acc. No. 61-011665/198601 (citing, Japanese Patent Application No. JP 59-131909, now Patent JP84141909, published Jan. 20, 1986) [see item FV].
Doktycz et al., "Analysis of Polymerase Chain Reaction-Amplified DNA Products by Mass Spectrometry Using Matrix Assisted Laser Desorption and Electrospray: Current Status" Anal. Biochem. 230: 205-214 (1995).
Eckstein (ed.), Oligonucleotides and Analogues, IRL Press, Oxford (1991).
Edmonds et al., Thermospray liquid chromatography-mass spectrometry of nucleosides and of enzymatic hydrolysates of nucleic acids, Nucleic Acids Research 13: 8197-8206 (1985).
Ehring et al., Photochemical versus thermal mechanisms in matrix-assisted laser desorption/ionization probed by back side desorption, Rapid Comm in Mass Spect 10: 821-824 (1996).
Feng et al., The RNA Component of Human Telomerase, Science 269(5228): 1236-1241 (1995).
Ferrie et al., Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene, Am. J. Hum. Genet. 51: 251-262 (1992).
Frank and Koster, DNA chain length and the influence of base composition on electrophoretic mobility of oligodeoxyribonucleotides in polyacrylamide-gels, Nucl. Acids Res. 6: 2069-2087 (1979).
Fu et al., A DNA sequencing strategy which requires only five bases of known terminal sequence for priming, Paper presented, Genome Mapping and Sequencing Conference, Cold Spring Harbor Laboratory, N.Y. May 10-14, 1995.
Fu et al., Sequencing double-stranded DNA by strand displacement, Nucl Acids Res 25: 677-679 (1997).
Fu et al., A DNA sequencing strategy that requires only five bases of known terminal sequence for priming, Proc. Natl. Acad. Sci. USA 92: 10162-10166 (1995).
Fu et al., Efficient preparation of short DNA sequence ladders potentially suitable for MALDI-TOF DNA sequencing, Genetic Analysis 12: 137-142 (1996).
Fu et al., Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry, Nat Biotechnol 16: 381-384 (1998).
Ganem et al., Detection of oligonucleotides duplex forms by ion-spray mass spectrometry, Tetrahedron Letters 34(9): 1445-1448 (1993).
Genetics in Medicine, Thompson, J.S. and M.W. Thompson, eds., W.B. Saunders Co., Philadelphia, PA (1986).
Gildea et al., A versatile acid-labile linker for modification of synthetic biomolecules, Tetrahedron Letters 31: 7095-7098 (1990).
Gross et al., Investigations of the metastable decay of DNA under ultraviolet matrix-assisted laser desorption/ionization conditions with post-source-decay analysis and hydrogen/deuterium exchange, J Amer Soc for Mass Spect 9: 866-878 (1998).
Gruic-Sovulj I. et al., Matrix-assisted laser desorption/ionization mass spectrometry of transfer ribonucleic acids isolated from yeast, Nucleic Acids Res. 25(9): 1859-61 (1997).
Gust et al., Taxonomic classification of Hepatitis A virus, Interviroloy 20: 1-7 (1983).
Guyader et al., Genome organization and transactivation of the human immunodeficiency virus type 2, Nature 328: 662-669 (1987).
Haglund et al., Matrix-assisted laser-desorption mass spectrometry of DNA using an infrared free-electron laser, SPIE 1854: 117-128 (1993).
Higuchi et al., Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions, Bio/Technology 11: 1026-1030 (1993).
Hillenkamp et al., Matrix Assisted UV-Laser Desorption/Ionization: A New Approach to Mass Spectrometry of Large Biomolecules, Biological Mass Spectrometry, Editors: A. L. Burlingame and J. A. McCloskey, Elsevier Science Publishers, B. V., Amsterdam, pp. 49-61 (1989).
Hillenkamp et al., Laser desorption mass spectrometry Part 1: Basic mechanisms and techniques, Mass Spectrometry in the Biological Sciences: A tutorial, pp. 165-179 (1992).
Hsiung et al., A new simpler photoaffinity analogue of peptidyl rRNA, Nucl Acids Res 1: 1753-1762 (1974).
Human Gene Mutations, D.N. Cooper and M. Krawczak, BIOS Publishers, (1993).
Huth-Fehre et al., Matrix-assisted laser desorption mass spectrometry of oligodeoxythymidylic acids, Rapid Comm in Mass Spect 6: 209-213 (1992).
Jacobson et al., Applications of Mass Spectrometry to DNA Sequencing, Genet. Anal. Tech. Appl. 8(8): 223-229 (1991).
Jacobson et al., "Applications of mass spectrometry to DNA fingerprinting and DNA sequencing", International Symposium on the Forensic Aspects of DNA Analysis, pp. 1-18, Mar. 29-Apr. 2, 1993.
Ji et al., Two-dimensional electrophoretic analysis of proteins expressed by normal and cancerous human crypts: Application of mass spectrometry to peptide-mass fingerprinting, Electrophoresis 15: 391-405 (1994).
Juhasz et al., Applications of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry to oligonucleotide analysis, Anal. Chem. 68: 941-946 (1996).
Jurinke et al., Recovery of nucleic acids from immobilized biotin-streptavidin complexes using ammonium hydroxide and applications in MALDI-TOF mass spectrometry, Anal. Chem. 69: 904-910 (1997).
Jurinke et al., Detection of hepatitis B virus DNA in serum samples via nested PCR and MALDI-TOF mass spectrometry, Genetic Analysis 13: 67-71 (1996).
Jurinke et al., Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera, Genetic Analysis 14: 97-102 (1998).
Jurinke et al., Analysis of ligase chain reaction products via matrix-assisted laser desorption/ionization time-of-flight-mass spectrometry, Analyt Biochem 237: 174-181 (1996).
Kirpekar et al., DNA sequence analysis by MALDI mass spectromety, Nucleic Acids Res. 26: 2554-9 (1998).
Koster et al., A strategy for rapid and efficient DNA sequencing by mass spectrometry, Nature Biotech 14: 1123-1128 (1996).
Koster et al., Oligonucleotide Synthesis and Multiplex DNA Sequencing using Chemiluminescent Detection, Nucleic Acids Research, Symposium Series No. 24 pp. 318-321 (1991).
Koster et al., Well-defined insoluble primers for the enzymatic synthesis of oligo- and polynucleotides, Hoppe Seylers Z. Physiol. Chem. 359(11): 1579-1589 (1978).
Koster et al., Polymer support oligonucleotide synthesis--XV.sup.1,2, Tetrahedron 40: 102-112 (1984).
Koster et al., N-acyl protecting groups for deoxynucleotides: A quantitative and comparative study, Tetrahedron 37: 363-369 (1981).
Koster et al., Some improvements in the synthesis of DNA of biological interest, Nucl Acids Res 7: 39-59 (1980).
Kuppuswamy et al., Single nucleotide primer extension to detect genetic diseases: Experimental application to hemophilia B (factor IX) and cystic fibrosis genes, Proc. Natl. Acad. Sci. USA 88: 1143-1147 (1991).
Landegren et al., DNA diagnostic-Molecular techniques and automation, Science 242: 229-237 (1988).
Landegren et al., A ligase-mediated gene detection technique, Science 241: 1077-1080 (1988).
Lawrance et al., Megabase-scale mapping of the HLA gene complex by pulsed field gel electrophoresis, Science 235:1387-1389 (1987).
Li et al., High-Resolution MALDI Fourier Transform Mass Spectrometry of Oligonucleotides, Anal Chem 68: 2090-2096 (1996).
Light-Wahl et al., Observation of small oligonucleotide duplex by electrospray ionization mass spectrometry, J. Am. Chem. Soc. 115: 804-805 (1993).
Little et al., Verification of 50- to 100-mer DNA and RNA sequences with high-resolution mass spectrometry, Proc. Natl. Acad. Sci. USA 92: 2318-2322 (1995).
Little et al., Direct detection of synthetic and biologically generated double-stranded DNA by MALDI-TOF MS, J. Mass Spec 17: 1-8 (1997).
Little et al., Detection of RET proto-oncogene codon 634 mutations using mass spectrometry, J. Mol Med. 75: 745-750 (1997).
Little et al., Identification of apolipoprotein E polymorphisms using temperature cycled primer oligo base extension and mass spectrometry, Eur. J. Chem. Clin. Biochem. 35(7): 545-8 (1997).
Little et al., MALDI on a chip: analysis of arrays of low-femtomole to subfemtomole quantitites of synthetic oligonucleotides and DNA diagnostic products dispensed by a piezoelectric pipet, Anal Chem 69: 4540-4546 (1997).
Little et al., Mass spectrometry from miniaturized arrays for full comparative DNA analysis, Nature Med 3: 1413-1416 (1997).
Liu et al., Rapid screening of genetic polymorphisms using buccal cell DNA with detection by matrix-assisted laser desorption/ionization mass spectrometry, Rapid Comm in Mass Spect 9: 735-743 (1995).
Liu et al., "Use of a Nitrocellulose Film Substrate in Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for DNA Mapping and Screening", Anal. Chem. 67: 3482-3490 (1995).
Lopez-Galindez et al.,Characterization of genetic variation and 3'-adizo-3'deoxythymidine-resistance mutations of human immunodeficiency virus by the RNase A mismatch cleavage method, Proc. Natl. Acad. Sci. USA 88: 4280-4284 (1991).
Lyamichev et al., Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerase, Science 260(5109): 778-83 (1993).
Matthews and Kricka, Analytical strategies for the use of DNA probes, Analytical Biochem. 169: 1-25 (1988).
Methods in Enzymology vol. 193: Mass Spectrometry (McCloskey, editor), p. 425 Academic Press, New York (1990).
Mizusawa et al., Improvement of the Dideoxy Chain Termination Method of DNA Sequencing by use of Deoxy-7-Deazaguanosine Triphosphate in Place of dGTP, Nucleic Acids Research, vol. 14, No. 3, pp. 1319-1325 (1986).
Monforte and Becker, High-throughput DNA analysis by time-of-flight mass spectrometry, Nature Medicine 3: 360-362 (1997).
Naito et al., Detection of Tyrosine Hydroxylase mRNA and Minimal Neuroblastoma Cells by the Reverse Transcription-Polymerase Chain Reaction, European Journal of Cancer 27: 762-765 (1991).
Nelson et al., Time of flight mass spectrometry of nucleic acids by laser ablation and ionization from a frozen aqueous matrix, Rapid Comm. in Mass Spect. 4: 348-351 (1990).
Nelson et al., Volatilization of High Molecular Weight DNA by Pulsed Laser Ablation of Frozen Aqueous Solutions, Science 246: 1585-1587 (1989).
Nielsen et al., Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide, Science 254: 1497-1500 (1991).
Nikiforov et al., The use of 96-well polystyrene plates for DNA hybridization-based assays: an evaluation of different approaches to oligonucleotide immobilization, Anal Biochem 227: 201-209 (1995).
Nikiforov et al., Genetic bit analysis: a solid phase method for typing single nucleotide polymorphisms, Nucleic Acids Res 22(20): 4167-4175 (1994).
Nordhoff et al., Ion stability of nucleic acids in infrared matrix-assisted laser desorption/ionization mass spectrometry, Nuc Acids Res. 21: 3347-3357 (1993).
Nordoff et al., Matrix-assisted laser desorption/ionization mass spectrometry of nucleic acids with wavelength in the ultraviolet and infrared, Rapid Comm. Mass Spect 6: 771-776 (1992).
O'Donnell et al., MassArray as an enabling technology for the industrial-scale analysis of DNA, Genetic Engineering News 17(21): 39-41, Dec. 1997.
O'Donnell et al., High-density, covalent attachment of DNA to silicon wafers for analysis by MALDI-TOF, mass spectrometry, Analytical Chemistry 69: 2438-2443 (1997).
O'Donnell-Maloney et al., Microfabrication and array technologies for DNA sequencing and diagnostics, Genetic Analysis: Biomolecular Engineering 13: 151-157 (1996).
Ordoukhanian et al., Design and Synthesis of a Versatile Photocleavable DNA Building Block. Application to Phototriggered Hybridization, J. Am. Chem. Soc. 117: 9570-9571 (1995).
Organic Charge Transfer Complex by R. Foster, Academic Press (1969).
Overberg et al., Laser Desorption Mass Spectrometry. Part II Performance and Applications of Matrix-Assisted Laser Desorption/Ionization of Large Biomolecules, Mass Spectrometry in the Biological Sciences: A Tutorial. Editor: M. L. Gross, Kluwer Publications, The Netherlands, pp. 181-197 (1992).
Palejwala et al., Quantitative Multiplex Sequence Analysis of Mutational Hot Spots. Frequency and Specificity of Mutations Induced by a Site-Specific Ethenocytosine in M13 Viral DNA, Biochemistry 32: 4105-4111 (1993).
Pasini et al., RET mutations in human disease, Trends in Genetics 12(4): 138-144 (1996).
PCR, C.R. Newton and A. Graham, BIOS Publishers, (1994).
Pieles et al., Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a powerful tool for the mass and sequence analysis of natural and modified oligonucleotides, Nucleic Acids Res. 21(14): 3191-3196 (1993).
Pierce Catalog, pp. T123-T154, 1994.
Pomerantz et al., Determination of oligonucleotide composition from mass spectrometrically measured molecular weight, Am. Soc. Mass Spectrom. 4: 204-09 (1993).
Ratner et al., Complete nucleotide sequence of the AIDS virus, HTLV-III, Nature 313: 227-284 (1985).
Reactive Molecules, The neutral reactive intermediates in organic chemistry, by C. Wentrup, John Wiley & Sons (1984).
Rolfs et al., PCR: Clinical Diagnostics and Research, Springer-Verlag, (1992).
Ruppert et al., Preparation of plasmid DNA as sequencing templates in a microtiter plate format, Paper presented, Genome Mapping and Sequencing Conference, Cold Spring Harbor Laboratory, N.Y. May 10-14, 1995.
Ruppert et al., A filtration method for plasmid isolation using microtitier filter plates, Anal. Biochem. 230: 130-134 (1995).
Ruppert et al., A rapid and high throughput method for plasmid isolation, Presented: Automation in Mapping and DNA Sequencing Conference, Aug. 31-Sep. 2, 1994.
Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press (1989).
Schieltz et al., Progress towards DNA sequence determination using laser ablation time-of-flight mass spectrometry, paper presented at 40th ASMS Conference on Mass Spectrometry and Allied topics, Washington, D.C., Jun. 1992.
Schneider and Chait, Increased stability of nucleic acids containing 7-deaza-guanosine and 7-deaza-adenosine may enable rapid DNA sequencing by matrix-assisted laser desorption mass spectrometry, Nucleic Acids Res. 23(9): 1570-1575 (1995).
Schram, Mass spectrometry of nucleic acid components, Biomed. App. Mass Spectrom. 34: 203-287 (1990).
Seela and Roling, 7-deazapurine containing DNA: efficiency of c.sup.7 G.sub.d TP, c.sup.7 A.sub.d TP and c.sup.7 I.sub.d TP incorporation during PCR-amplification and protection from endodeoxyribonuclease hydrolysis, Nucleic Acids Res. 20: 55-61 (1992).
Seela and Kehne, Palindromic octa- and dodecanucleotides containing 2'-deoxytubercidin: Synthesis, hairpin formation, and recognition by the endodeoxyribonuclease EcoRI, Biochemistry 26: 2232-2238 (1987).
Sequenom Obtains Important New Patent for DNA MassArray.TM. Technology, Press Release: May 24, 1999, http://www.sequenom.com/pr/pressrelease/52499.html.
Sequenom Advances the Industrial Genomics Revolution with the Launch of Its DNA MassArray.TM.Automated Process Line, Press Release: Sep. 28, 1998, http://www.sequenom.com/pressrelease.htm.
Sequenom Reports DNA MassArray.TM.Technology More Sensitive Than Electrophoretic Methods in Detecting Gene Mutations: Automated DNA Analysis System Can Speed Up Microsatellite Analyses, Press Release: Dec. 15, 1997, http://www.sequenom.com/pressrelease.htm.
Sequenom Uses DNA MassArray.TM.to Sequence Section of Human Cancer-Related p53 Gene, Press Release: Mar. 27, 1998, http://www.sequenom.com/pressrelease.htm.
Sequenom Reports On Use of Its DNA MassArray.TM.Technology to Analyze Genes Associated with Alzheimer's Disease and Arterioslcerosis: Technology Has Applications in Drug Development, Press Release: Sep. 22, 1997, http://www.sequenom.com/pressrelease.htm.
Sequenom Obtains Patents for DNA MassArray.TM. Technology, Press Release: Apr. 27, 1999, http://www.sequenom.com/pressrelease/42799.htm.
Sequenom Signs Agreement With Bruker-Franzen Analytik to Develop Mass Spectrometer for DNA Massarray Analysis, Press Release: Jan. 12, 1998, http://www.sequenom.com/pressrelease.htm.
Shaler et al., Effect of Impurities on the matrix-assisted laser desorption mass spectra of single-stranded oligodeoxynucleotides, Anal. Chem. 68: 576-579 (1996).
Siegert et al., Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the detection of polymerase chain reaction products containing 7-deasapurine moieties, Anal. Biochem. 243: 55-65 (1996).
Sinha et al., Polymer support oligonucleotide synthesis XVIII: Use of B-cyanoethyl-N, N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of final product, Nucleic Acids Res. 12: 4539-4557 (1984).
Sinha et al., .beta.-cyanoethyl N, N-dialkylamino/N-morpholinomonochloro phosphoamidites, new phosphitylating agents facilitating ease of deprotection and work-up of synthesized oligonucleotides, Tetrahedron Lett. 24: 5843-5846 (1983).
Siuzdak, The emergence of mass spectrometry in biochemical research, Proc. Natl. Acad. Sci. USA 91: 11290-11297 (1994).
Smith et al., Capillary zone electrophoresis-mass spectrometry using an electrospray ionization interface, Anal. Chem. 60: 436-441 (1988).
Smith et al., New Developments in Biochemical Mass Spectrometry: Electrospray Ionization, Anal. Chem. 62: 882-899 (1990).
Sokolov, Primer extension technique for the detection of single nucleotide in genomic DNA, Nucleic Acid Res. 18(12): 3671 (1990).
Sproat et al., The synthesis of protected 5'-amino-2',5'-dideoxyribonucleoside-3'-O-phosphoramidites; applications of 5'-amino-oligodeoxyribonucleotides, Nucleic Acids Res. 15: 6181-6196 (1987).
Stahl et al., Solid Phase DNA Sequencing using the Biotin-Avidin System, Nucleic Acids Research 16(7): 3025-3039 (1988).
Syvanen et al., Detection of Point Mutations by Solid-Phase Methods, Human Mutation 3(3): 172-179 (1994).
Tang et al., Matrix-assisted laser desorption/ionization mass spectrometry of immobilized duplex DNA probes, Nucleic Acid Res. 23(16): 3126-3131 (1995).
Tang et al., Matrix-assisted Laser Desorption/Ionization of Restriction Enzyme-digested DNA, Rapid Communications in Mass Spectrometry 8(2): 183-186 (1994).
Tang et al., Detection of 500-nucleotide DNA by laser desorption mass spectrometry, Rapid Commun. Mass Spectrom. 8: 727-730 (1994).
Tang, et al., Improving mass resolution in MALDI/TOF analysis of DNA, American Society of Mass Spectrometrists Conference: May 21 to 26, 1995.
The Human Genome, T. Strachan, BIOS Scientific Publishers (1992).
Time of Flight Mass Spectrometry of DNA for Rapid Sequence Determination. Technical Progress Report, Jul. 31, 1991-Jul. 31, 1992, Arizona State University., Tempe.
Trainor, DNA Sequencing, Automation and the Human Genome, Anal. Chem. 62: 418-426 (1990).
Valaskovic, et al., Attomole-sensitivity electrospray source for large-molecule mass spectrometry, Anal. Chem. 67: 3802-3805 (1995).
Vorm et al., Improved resolution and very high sensitivity in MALDI TOF of matrix surfaces made by fast evaporation, Anal. Chem. 66: 3281-3287 (1994).
Wain-Hobson et al., Nucleotide sequence of the AIDS virus, LAV, Cell 40: 9-17 (1985).
Walker et al., Multiplex strand displacement amplification (SDA) and detection of DNA sequences from Mycobacterium tuberculosis and other mycobacteria, Nucleic Acids Res. 22(13): 2670-2677 (1994).
Wang, Solid phase synthesis of protected peptides via photolytic cleavage of the .alpha.-methylphenacyl ester anchoring linkage, J. Org. Chem. 41(20): 32583-261 (1976).
Wiedmann M. et al., Ligase chain reaction (LCR)--overview and applications, PCR Methods Appl. 3(4): S51-S64 (1994).
William, Time of flight mass spectrometry of DNA laser-ablated from frozen aqueous solutions: applications to the Human Genome Project, Intl. J. Mass Spectrom. and Ion Processes 131: 335-344 (1994).
Wolter et al., Negative ion FAB mass spectrometric analysis of non-charged key intermediated in oligonucleotide synthesis: rapid identification of partially protected dinucleoside monophosphates, Biomedical Environmental Mass Spectrometry 14: 111-116 (1987).
Wong, Ch. 12: Conjugation of proteins to solid matrices, Chemistry of Protein Conjugation and Cross Linking 12: 295-217 (1993).
Wu et al., Matrix-assisted Laser Desorption Time-of-flight Mass Spectrometry of Oligonucleotides Using 3-Hydroxypicolinic Acid as an Ultraviolet-sensitive Matrix, Rapid Comm Mass Spec 7: 142-146 (1993).
Wu et al., Time-of-Flight Mass Spectrometry of Underivatized Single-Stranded DNA Oligomers by Matrix-Assisted Laser Desorption, Anal. Chem. 66: 1637-1645 (1994).
Wu et al., Allele-specific enzymatic amplification of .beta.-globin genomic DNA for diagnosis of sickle cell anemia, Proc. Natl. Acad. Sci. USA 86: 2757-2760 (1989).
Yamashita et al., Electrospray ion source. Another variation on the free-jet theme, J. Phys. Chem. 88: 4451-4459 (1984).
Bai et al., "Matrix-Assisted Laser Desprption/Ionization Mass Spectrometry of Restriction Enzyme-Digested Plasmid DNA Using an Active Nafion Substrate", Rapid Comm. Mass Spec., 8:687-691 (1994).
Bannwarth, "Solid-phase synthesis of oligodeoxynucleotides containing phosphoramidate internucleotide linkages and their specific chemical cleavage", Helvetica Chimica Acta, 71:1517-1525 (1988).
Benner and Jaklevic, "DNA Base-Pair Substitutions Detected in Double-Stranded DNA With Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry", Eur. Mass Spectrum., 1:479-485 (1995).
Chang et al., "Detection of .DELTA.F508 Mutation of the cystic Fibrosis Gene by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry", Rapid Comm. in Mass Spectrom., 9:772-774 (1995).
Cosstick et al., "Synthesis and Properties of dithymidine phosphate analogues containing 3'-thiothimidine", Nucl. Acid Res., 18:829-835 (1990).
Fitzgrald et al., "Basic Matrices for the Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry of Proteins and Oligonucleotides", Anal. Chem., 65:3204-3211 (1993).
Liu et al., "Use of Nitrocellulose Film Substrate in Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for DNA Mapping and Screening", Anal. Chem., 67:3482-3490 (1995).
Nakayame et al., "Direct Sequencing of polymerase chain reaction amplified DNA fragments through the incorporation of deoxynucleoside a-thiotriphosphates", Nucl. Acids Res., 16:9947-9959 (1988).
Siegert et al., "Matrix-assisted laser desorption/ionization Time-of-flight mass Spectrometry for the detection of polymerase chain reaction products containing 7-Deazapurinr moieties", Anal. Biochem., 243:55-65 (1966).
Wu et al., The ligation amplification reaction (LAR)-amplification of specific DNA sequences using sequential rounds of template-dependent ligation Genomics, 4:560-569 (1989).

PATENT PARENT CASE TEXT This data is not available for free
PATENT CLAIMS What is claimed is:

1. A process for detecting one or more target nucleic acid sequences in a biological sample, comprising:

a) digesting nucleic acids from the sample;

b) analyzing digested fragments by mass spectrometry;

c) detecting a target nucleic acid sequence by a specific molecular weight, wherein detection of the target nucleic acid by mass spectrometry indicates the presence of the target nucleic acid sequence in the biological sample.

2. The process of claim 1, further comprising the step of amplifying nucleic acid molecules in the sample prior to analysis.

3. The process of claim 1, wherein the digested fragments are conditioned prior to mass spectrometric analysis.

4. The process of claim 1, wherein dection of a target nucleic acid sequence in the sample provides a genetic diagnosis, detects chromosomal aneuploidy, detects a genetic predisposition to a disease or condition, or detects or identifies infection by a pathogen.

5. The process of claim 1, wherein a plurality of nucleic acids from the sample are immobilized on a solid support prior to mass spectrometric analysis.

6. The method of claim 5, wherein the nucleic acids are in an array and each spot on the array is subjected to mass spectrometric analysis.

7. The process of claim 5, wherein immobilization is effected by a bond cleavable by a pyrophosphatase.

8. The process of claim 7, wherein immobilization is effected by a bond cleavable by pyrophosphatase.

9. The process of claim 1, herein a nucleic acid comprising the target sequence has been contacted with an alkylating agent prior to mass spectrometric analysis.

10. The process of claim 1, wherein a nucleic acid comprising the target sequence includes one or more of the following: nucleotides that reduce sensitivity for depurination, RNA building blocks, phosphorothioate groups, nucleic acid mimetics and protein nucleic acid (PNA).

11. The process of claim 10, wherein the target nucleic acid includes an alkylated phosphorothioate group.

12. A process for detecting one or more target nucleic acid sequences in a biological sample, comprising:

a) amplifying nucleic acids from the sample;

b) analyzing nucleic acids in the sample by mass spectrometry;

c) detecting a target nucleic acid sequence by a specific molecular weight, wherein detection of the target nucleic acid by mass spectrometry indicates the presence of the target nucleic acid sequence in the biological sample.

13. The process of claim 12, wherein nucleic acids are conditioned prior to mass spectrometric analysis.

14. The process of claim 12, wherein dection of a target nucleic acid sequence in the sample provides a genetic diagnosis, detects chromosomal aneuploidy, detects a genetic predisposition to a disease or condition, or detects or identifies infection by a pathogen.

15. The process of claim 12, wherein a plurality of nucleic acids from the sample are immobilized on a solid support prior to mass spectrometric analysis.

16. The process of claim 15, wherein immobilization is effected by a bond cleavable by a pyrophosphatase.

17. The process of claim 16, wherein immobilization is effected by a bond cleavable by pyrophosphatase.

18. The method of claim 12, wherein the nucleic acids are arranged in an array and each spot on the array is subjected to mass spectrometric analysis.

19. The process of claim 12, wherein a nucleic acid comprising the target sequence has been contacted with an alkylating agent prior to mass spectrometric analysis.

20. The process of claim 12, wherein a nucleic acid comprising the target sequence includes one or more of the following: nucleotides that reduce sensitivity for depurination, RNA building blocks, phosphorothioate groups, nucleic acid mimetics and protein nucleic acid (PNA).

21. The process of claim 12, wherein the target nucleic acid includes an alkylated phosphorothioate group
PATENT DESCRIPTION BACKGROUND OF THE INVENTION

The genetic information of all living organisms (e.g. animals, plants and microorganisms) is encoded in deoxyribonucleic acid (DNA). In humans, the complete genome is comprised of about 100,000 genes located on 24 chromosomes (The Human Genome, T. Strachan, BIOS Scientific Publishers, 1992). Each gene codes for a specific protein which after its expression via transcription and translation, fulfills a specific biochemical function within a living cell. Changes in a DNA sequence are known as mutations and can result in proteins with altered or in some cases even lost biochemical activities; this in turn can cause genetic disease. Mutations include nucleotide deletions, insertions or alterations (i.e. point mutations). Point mutations can be either "missense", resulting in a change in the amino acid sequence of a protein or "nonsense" coding for a stop codon and thereby leading to a truncated protein.

More than 3000 genetic diseases are currently known (Human Genome Mutations, D. N. Cooper and M. Krawczak, BIOS Publishers, 1993), including hemophilias, thalassemias, Duchenne Muscular Dystrophy (DMD), Huntington's Disease (HD), Alzheimer's Disease and Cystic Fibrosis (CF). In addition to mutated genes, which result in genetic disease, certain birth defects are the result of chromosomal abnormalities such as Trisomy 21 (Down's Syndrome), Trisomy 13 (Patau Syndrome), Trisomy 18 (Edward's Syndrome), Monosomy X (Turner's Syndrome) and other sex chromosome aneuploidies such as Klienfelter's Syndrome (XXY). Further, there is growing evidence that certain DNA sequences may predispose an individual to any of a number of diseases such as diabetes, arteriosclerosis, obesity, various autoimmune diseases and cancer (e.g. colorectal, breast, ovarian, lung).

Viruses, bacteria, fungi and other infectious organisms contain distinct nucleic acid sequences, which are different from the sequence contained in the host cell. Therefore, infectious organisms can also be detected and identified based on their specific DNA sequences.

Since the sequence of about 16 nucleotides is specific on statistical grounds even for the size of the human genome, relatively short nucleic acid sequences can be used to detect normal and defective genes in higher organisms and to detect infectious microorganisms (e.g. bacteria, fungi, protists and yeast) and viruses. DNA sequences can even serve as a fingerprint for detection of different individuals within the same species. (Thompson, J. S. and M. W. Thompson, eds., Genetics in Medicine, W. B. Saunders Co., Philadelphia, Pa. (1986).

Several methods for detecting DNA are currently being used. For example, nucleic acid sequences can be identified by comparing the mobility of an amplified nucleic acid fragment with a known standard by gel electrophoresis, or by hybridization with a probe, which is complementary to the sequence to be identified. Identification, however, can only be accomplished if the nucleic acid fragment is labeled with a sensitive reporter function (e.g. radioactive (.sup.32 P, .sup.35 S), fluorescent or chemiluminescent). However, radioactive labels can be hazardous and the signals they produce decay over time. Non-isotopic labels (e.g. fluorescent) suffer from a lack of sensitivity and fading of the signal when high intensity lasers are being used. Additionally, performing labeling, electrophoresis and subsequent detection are laborious, time-consuming and error-prone procedures. Electrophoresis is particularly error-prone, since the size or the molecular weight of the nucleic acid cannot be directly correlated to the mobility in the gel matrix. It is known that sequence specific effects, secondary structures and interactions with the gel matrix are causing artifacts.

In general, mass spectrometry provides a means of "weighing" individual molecules by ionizing the molecules in vacuo and making them "fly" by volatilization. Under the influence of combinations of electric and magnetic fields, the ions follow trajectories depending on their individual mass (m) and charge (z). In the range of molecules with low molecular weight, mass spectrometry has long been part of the routine physical-organic repertoire for analysis and characterization of organic molecules by the determination of the mass of the parent molecular ion. In addition, by arranging collisions of this parent molecular ion with other particles (e.g. argon atoms), the molecular ion is fragmented forming secondary ions by the so-called collision induced dissociation (CID). The fragmentation pattern/pathway very often allows the derivation of detailed structural information. Many applications of mass spectrometric methods are known in the art, particularly in biosciences, and can be found summarized in Methods of Enzymology, Vol. 193:"Mass Spectrometry" (J. A. McCloskey, editor), 1990, Academic Press, New York.

Due to the apparent analytical advantages of mass spectrometry in providing high detection sensitivity, accuracy of mass measurements, detailed structural information by CID in conjunction with an MS/MS configuration and speed, as well as on-line data transfer to a computer, there has been considerable interest in the use of mass spectrometry for the structural analysis of nucleic acids. Recent reviews summarizing this field include K. H. Schram, "Mass Spectrometry of Nucleic Acid Components, Biomedical Applications of Mass Spectrometry" 34, 203-287 (1990); and P. F. Crain, "Mass Spectrometric Techniques in Nucleic Acid Research, "Mass Spectrometry Reviews 9, 505-554 (1990).

However, nucleic acids are very polar biopolymers that are very difficult to volatilize. Consequently, mass spectrometric detection has been limited to low molecular weight synthetic oligonucleotides by determining the mass of the parent molecular ion and through this, confirming the already known oligonucleotide sequence, or alternatively, confirming the known sequence through the generation of secondary ions (fragment ions) via CID in the MS/MS configuration utilizing, in particular, for the ionization and volatilization, the method of fast atomic bombardment (FAB mass spectrometry) or plasma desorption (PD mass spectrometry). As an example, the application of FAB to the analysis of protected dimeric blocks for chemical synthesis of oligodeoxynucleotides has been described (Wolter et al. Biomedical Environmental Mass Spectrometry 14: 111-116 (1987)).

Two more recent ionizations/desorption techniques are electrospray/ionspray (ES) and matrix-assisted laser desorption/ionization (MALDI). ES mass spectrometry has been introduced by Yamashita et al. (J. Phys. Chem. 88: 4451-59 (1984); PCT Application No. WO 90/14148) and current applications are summarized in recent review articles (R. D. Smith et al., Anal. Chem. 62: 882-89 (1990) and B. Ardrey, Electrospray Mass Spectrometry, Spectroscopy Europe 4: 10-18 (1992)). The molecular weights of a tetradecanucleotide (Covey et al. "The Determination of Protein, Oligonucleotide and Peptide Molecular Weights by Ionspray Mass Spectrometry," Rapid Communications in Mass Spectrometry 2: 249-256 (1988)), and of a 21-mer (Methods in Enzymology 193, "Mass Spectrometry" (McCloskey, editor), p. 425, 1990, Academic Press, New York) have been published. As a mass analyzer, a quadrupole is most frequently used. The determination of molecular weights in femtomole amounts of sample is very accurate due to the presence of multiple ion peaks which all could be used for the mass calculation.

MALDI mass spectrometry, in contrast, can be particularly attractive when a time-of-flight (TOF) configuration is used as a mass analyzer. The MALDI-TOF mass spectrometry has been introduced by Hillenkamp et al. ("Matrix Assisted UV-Laser Desorption/lonization: A New Approach to Mass Spectrometry of Large Biomolecules," Biological Mass Spectrometry (Burlingame and McCloskey, editors), Elsevier Science Publishers, Amsterdam, pp. 49-60, 1990). Since, in most cases, no multiple molecular ion peaks are produced with this technique, the mass spectra, in principle, look simpler compared to ES mass spectrometry.

Although DNA molecules up to a molecular weight of 410,000 daltons have been desorbed and volatilized (Nelson et al., "Volatilization of High Molecular Weight DNA by Pulsed Laser Ablation of Frozen Aqueous Solutions, Science 246: 1585-87 (1989)), this technique has so far only shown very low resolution (oligothymidylic acids up to 18 nucleotides, Huth-Fehre et al., Rapid Communications in Mass Spectrometry 6: 209-13 (1992); DNA fragments up to 500 nucleotidase in length, Tang, K. et al., Rapid Communications in Mass Spectrometry 8: 727-730 (1994); and a double-stranded DNA of 28 base pairs (Williams et al., "Time-of Flight Mass Spectrometry of Nucleic Acids by Laser Ablation and Ionization from a Frozen Aqueous Matrix," Rapid Communications in Mass Spectrometry 4: 348-351 (1990)).

Japanese Patent No. 59-131909 describes an instrument, which detects nucleic acid fragments separated either by electrophoresis, liquid chromatography or high speed gel filtration. Mass spectrometric detection is achieved by incorporating into the nucleic acids, atoms which normally do not occur in DNA such as S, Br, I or Ag, Au, Pt, Os, Hg.

SUMMARY OF THE INVENTION

The instant invention provides mass spectrometric processes for detecting a particular nucleic acid sequence in a biological sample. Depending on the sequence to be detected, the processes can be used, for example, to diagnose (e.g. prenatally or postnatally) a genetic disease or chromosomal abnormality; a predisposition to a disease or condition (e.g. obesity, atherosclerosis, cancer), or infection by a pathogenic organism (e.g. virus, bacteria, parasite or fungus); or to provide information relating to identity, heredity, or compatibility (e.g. HLA phenotyping).

In a first embodiment, a nucleic acid molecule containing the nucleic acid sequence to be detected (i.e. the target) is initially immobilized to a solid support. Immobilization can be accomplished, for example, based on hybridization between a portion of the target nucleic acid molecule, which is distinct from the target detection site and a capture nucleic acid molecule, which has been previously immobilized to a solid support. Alternatively, immobilization can be accomplished by direct bonding of the target nucleic acid molecule and the solid support. Preferably, there is a spacer (e.g. a nucleic acid molecule) between the target nucleic acid molecule and the support. A detector nucleic acid molecule (e.g. an oligonucleotide or oligonucleotide mimetic), which is complementary to the target detection site can then be contacted with the target detection site and formation of a duplex, indicating the presence of the target detection site can be detected by mass spectrometry. In preferred embodiments, the target detection site is amplified prior to detection and the nucleic acid molecules are conditioned. In a further preferred embodiment, the target detection sequences are arranged in a format that allows multiple simultaneous detections (multiplexing), as well as parallel processing using oligonucleotide arrays ("DNA chips").

In a second embodiment, immobilization of the target nucleic acid molecule is an optional rather than a required step. Instead, once a nucleic acid molecule has been obtained from a biological sample, the target detection sequence is amplified and directly detected by mass spectrometry. In preferred embodiments, the target detection site and/or the detector oligonucleotides are conditioned prior to mass spectrometric detection. In another preferred embodiment, the amplified target detection sites are arranged in a format that allows multiple simultaneous detections (multiplexing), as well as parallel processing using oligonucleotide arrays ("DNA chips").

In a third embodiment, nucleic acid molecules which have been replicated from a nucleic acid molecule obtained from a biological sample can be specifically digested using one or more nucleases (using deoxyribonucleases for DNA or ribonucleases for RNA) and the fragments captured on a solid support carrying the corresponding complementary sequences. Hybridization events and the actual molecular weights of the captured target sequences provide information on whether and where mutations in the gene are present. The array can be analyzed spot by spot using mass spectrometry. DNA can be similarly digested using a cocktail of nucleases including restriction endonucleases. In a preferred embodiment, the nucleic acid fragments are conditioned prior to mass spectrometric detection.

In a fourth embodiment, at least one primer with 3' terminal base complementarity to a an allele (mutant or normal) is hybridized with a target nucleic acid molecule, which contains the allele. An appropriate polymerase and a complete set of nucleoside triphosphates or only one of the nucleoside triphosphates are used in separate reactions to furnish a distinct extension of the primer. Only if the primer is appropriately annealed (i.e. no 3' mismatch) and if the correct (i.e. complementary) nucleotide is added, will the primer be extended. Products can be resolved by molecular weight shifts as determined by mass spectrometry.

In a fifth embodiment, a nucleic acid molecule containing the nucleic acid sequence to be detected (i.e. the target) is initially immobilized to a solid support. Immobilization can be accomplished, for example, based on hybridization between a portion of the target nucleic acid molecule, which is distinct from the target detection site and a capture nucleic acid molecule, which has been previously immobilized to a solid support. Alternatively, immobilization can be accomplished by direct bonding of the target nucleic acid molecule and the solid support. Preferably, there is a spacer (e.g. a nucleic acid molecule) between the target nucleic acid molecule and the support. A nucleic acid molecule that is complementary to a portion of the target detection site that is immediately 5' of the site of a mutation is then hybridized with the target nucleic acid molecule. The addition of a complete set of dideoxynucleosides or 3'-deoxynucleoside triphosphates (e.g. pppAdd, pppTdd, pppCdd and pppGdd) and a DNA dependent DNA polymerase allows for the addition only of the one dideoxynucleoside or 3'-deoxynucleoside triphosphate that is complementary to X. The hybridization product can then be detected by mass spectrometry.

In a sixth embodiment, a target nucleic acid is hybridized with a complementary oligonucleotides that hybridize to the target within a region that includes a mutation M. The heteroduplex is than contacted with an agent that can specifically cleave at an unhybridized portion (e.g. a single strand specific endonuclease), so that a mismatch, indicating the presence of a mutation, results in a the cleavage of the target nucleic acid. The two cleavage products can then be detected by mass spectrometry.

In a seventh embodiment, which is based on the ligase chain reaction (LCR), a target nucleic acid is hybridized with a set of ligation educts and a thermostable DNA ligase, so that the ligase educts become covalently linked to each other, forming a ligation product. The ligation product can then be detected by mass spectrometry and compared to a known value. If the reaction is performed in a cyclic manner, the ligation product obtained can be amplified to better facilitate detection of small volumes of the target nucleic acid. Selection between wildtype and mutated primers at the ligation point can result in a detection of a point mutation.

The processes of the invention provide for increased accuracy and reliability of nucleic acid detection by mass spectrometry. In addition, the processes allow for rigorous controls to prevent false negative or positive results. The processes of the invention avoid electrophoretic steps, labeling and subsequent detection of a label. In fact it is estimated that the entire procedure, including nucleic acid isolation, amplification, and mass spec analysis requires only about 2-3 hours time. Therefore the instant disclosed processes of the invention are faster and less expensive to perform than existing DNA detection systems. In addition, because the instant disclosed processes allow the nucleic acid fragments to be identified and detected at the same time by their specific molecular weights (an unambiguous physical standard), the disclosed processes are also much more accurate and reliable than currently available procedures.

PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back